Biogen (BIIB) Total Liabilities (2009 - 2026)
Biogen (BIIB) posted Total Liabilities of $13.24 billion for Q2 2026, up 23.8% from $10.7 billion a year earlier and up 22.2% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Total Liabilities (2009 - 2026) Analysis & Trends
At the end of FY2025, Biogen's Total Liabilities came in at $11.18 billion, down 1.3% from FY2024.
- Annual Total Liabilities shows a five-year compound annual growth rate of -4.3% (FY2020 to FY2025).
- In prior years, Biogen's Total Liabilities was $11.33 billion in FY2024 (-5.9%), $12.05 billion in FY2023 (+7.9%), $11.17 billion in FY2022 (-13.6%) and $12.92 billion in FY2021 (-7.3%).
- The Q2 2026 figure stands as the highest quarterly Total Liabilities since Q3 2023.
- On a year-over-year basis, Total Liabilities increased in 1 of the last eight quarters, with an average decline of 1.4%.
- The strongest year-over-year quarter for Total Liabilities in the past five years was Q2 2026, with growth of 23.8%; the weakest was Q2 2023, with a decline of 19.1%.
- According to Business Quant data, Total Liabilities for the three prior quarters was $10.83 billion (Q1 2026), $11.18 billion (Q4 2025) and $11 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 108.40 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 115.90 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 141.05 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 87.82 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 80.09 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 65.46 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 83.95 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 37.53 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 115.64 Bn |
| 10 | Biogen | 36.99 Bn | 23.65 Bn | 1.96 Bn | 13.24 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.24 Bn |
| Mar 31, 2026 | 10.83 Bn |
| Dec 31, 2025 | 11.18 Bn |
| Sep 30, 2025 | 11.00 Bn |
| Jun 30, 2025 | 10.70 Bn |
| Mar 31, 2025 | 11.05 Bn |
| Dec 31, 2024 | 11.33 Bn |
| Sep 30, 2024 | 11.95 Bn |
| Jun 30, 2024 | 10.92 Bn |
| Mar 31, 2024 | 11.35 Bn |
| Dec 31, 2023 | 12.05 Bn |
| Sep 30, 2023 | 13.71 Bn |
| Jun 30, 2023 | 10.70 Bn |
| Mar 31, 2023 | 10.81 Bn |
| Dec 31, 2022 | 11.17 Bn |
| Sep 30, 2022 | 12.09 Bn |
| Jun 30, 2022 | 13.22 Bn |
| Mar 31, 2022 | 12.39 Bn |
| Dec 31, 2021 | 12.92 Bn |
| Sep 30, 2021 | 12.93 Bn |
API Access
Biogen Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();